Cited by 46Parathyroid Disorders and TreatmentsVitamin D Research StudiesAlkaline Phosphatase Research Studies

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3

Open access
Kägi, Larissa, Bettoni, Carla, Pastor-Arroyo, Eva M., Schnitzbauer, Udo, Hernando, Nati, Wagner, Carsten A.·2018·PLOS ONE

Abstract

BACKGROUND: The 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) together with parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) regulates calcium (Ca2+) and phosphate (Pi) homeostasis, 1,25(OH)2D3 synthesis is mediated by hydroxylases of the cytochrome P450 (Cyp) family. Vitamin D is first modified in the liver by the 25-hydroxylases CYP2R1 and CYP27A1 and further activated in the kidney by the 1α-hydroxylase CYP27B1, while the renal 24-hydroxylase CYP24A1 catalyzes the first step of its inactivation. While the kidney is the main organ responsible for circulating levels of active 1,25(OH)2D3, other organs also express some of these enzymes. Their regulation, however, has been studied less. METHODS AND RESULTS: Here we investigated the effect of several Pi-regulating factors including dietary Pi, PTH and FGF23 on the expression of the vitamin D hydroxylases and the vitamin D receptor VDR in renal and extrarenal tissues of mice. We found that with the exception of Cyp24a1, all the other analyzed mRNAs show a wide tissue distribution. High dietary Pi mainly upregulated the hepatic expression of Cyp27a1 and Cyp2r1 without changing plasma 1,25(OH)2D3. FGF23 failed to regulate the expression of any of the studied hydroxylases at the used dosage and treatment length. As expected, renal mRNA expression of Cyp27b1 was reduced and Cyp24a1 was increased in response to 1,25(OH)2D3 treatment. However, the 25-hydroxylases were rather unaffected by 1,25(OH)2D3 treatment. CONCLUSIONS: The analyzed vitamin D hydroxylases are regulated in a tissue and treatment-specific manner.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0195427

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lower calcitriol levels likely reflect suppression of the calcitriol-synthesizing enzyme CYP27B1 and stimulation of the catabolic CYP24A1 enzyme by iFGF23, as observed in animal studies.

    “lower calcitriol levels likely reflecting the suppression of calcitriol synthesizing enzyme CYP27B1 and stimulation of the catabolic CYP24A1 enzyme by iFGF23 as observed in animal studies [31, 33, 51].”

    From Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels (2025) · cites this paper as [31]

    The Introduction says FGF23 downregulates renal CYP27B1, induces CYP24A1, and suppresses calcitriol production. In Results & discussion (page not provided), the authors report that earlier mouse experiments found these enzyme changes and lower calcitriol shortly after FGF23 treatment, but that the effects were transient; their own FGF23-treated mice showed no significant change in either enzyme’s expression or in calcitriol. The claim omits that timing qualification and does not reflect this study’s experimental result. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [43]Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Min Res 2004; 19(3): 429– 35. 15040831
  2. [48]Murayama A, Takeyama K, Kitanaka S, Kodera Y, Hosoya T, Kato S. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. Biochem Biophys Res Commun. 1998; 249(1): 11– 6. 9705822

Cited by

Sorted by citations

Authors
Kägi, L., Bettoni, C., Pastor-Arroyo, E. M., Schnitzbauer, U., Hernando, N., & Wagner, C. A.
Affiliations
University of Zurich (CH)
Corresponding author
Wagner, Carsten A.
Venue
PLOS ONE
Published
2018-05-17
Volume
13
Issue
5
Pages
e0195427
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2803128906
Cited by
46
References
51
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 4
FWCI
4.71
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_176125)
Topics
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Vitamin D Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
Keywords
vitamin D metabolism, vitamin D hydroxylases, CYP27B1, CYP24A1, CYP2R1, CYP27A1, 1,25-dihydroxyvitamin D3, fibroblast growth factor 23, dietary phosphorus, parathyroid hormone, vitamin D receptor, renal vitamin D metabolism, calcium and phosphate homeostasis, gene expression regulation
MeSH terms
Fibroblast Growth Factor-23, Animals, Calcitriol, Cytochrome P-450 Enzyme System, Diet, Fibroblast Growth Factors, Homeostasis, Humans, Kidney, Male, Parathyroid Hormone, Phosphates, Vitamin D, Gene Expression Regulation, Enzymologic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review